AMBIEN
Pronunciation: ZOL-pi-dem (AM-bee-un)


What it isAlpha-1-preferring GABA-A positive allosteric modulator; short-term treatment of insomnia.
Why this oneIt targets sleep onset with less broad muscle-relaxant and anxiolytic action than benzodiazepines, but is not dependence-free.
What limits itStop after any complex sleep behavior. Next-day impairment is worse in slower clearers; repeated use brings tolerance and rebound insomnia.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Insomnia (sleep-onset) | Women | 5 mg QHS | 10 mg QHS | |
| Insomnia (sleep-onset) | Men | 5 or 10 mg QHS | 10 mg QHS | |
| Insomnia (sleep-onset) | Elderly/debilitated | 5 mg QHS | 5 mg QHS |
Renal Undefined
Hepatic Mild-moderate: 5 mg QHS; avoid in severe impairment (may precipitate encephalopathy)
Do not exceed 10 mg once daily; single dose per night, do not redose
Available strengths
Pregnancy Late third-trimester use may cause neonatal respiratory depression and sedation; no clear association with major birth defects.
Lactation Present in human milk; monitor infant for excess sedation; may pump and discard milk for 23 h after a dose.
| Strength | #/mo | generic $/mo | CostPlus | |
|---|---|---|---|---|
| 5 mg | tab | 30 qd | $1.03 | not offered |
| 10 mg | tab | 30 qd | $1.19 | not offered |
Other forms: Zolpidem CR (AMBIEN CR) · Zolpidem SL (EDLUAR)
Generic entry2007
⚠ BOXED WARNING
Legacy pregnancy categoryC
Defining liabilityComplex sleep behaviors, next-day impairment, falls and additive CNS depression.
Open Zolpidem in the interactive console ↗
